Graft vs Tumor Effect
This graph shows the total number of publications written about "Graft vs Tumor Effect" by people in the URMC Research Network by year, and whether "Graft vs Tumor Effect" was a major or minor topic of these publication.
Below are the most recent publications written about "Graft vs Tumor Effect" by people in Profiles.
-
Cairo MS, Jordan CT, Maley CC, Chao C, Melnick A, Armstrong SA, Shlomchik W, Molldrem J, Ferrone S, Mackall C, Zitvogel L, Bishop MR, Giralt SA, June CH. NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science. Biol Blood Marrow Transplant. 2010 Jun; 16(6):709-28.
-
Liesveld JL, Rothberg PG. Mixed chimerism in SCT: conflict or peaceful coexistence? Bone Marrow Transplant. 2008 Sep; 42(5):297-310.
-
Mundhada S, Shaw J, Mori S, Savary CA, Mullen CA. Cellular tumor vaccines administered after T cell-depleted allogeneic bone marrow transplantation induce effective anti-tumor immune responses. Leuk Lymphoma. 2005 Apr; 46(4):571-80.
-
Mullen CA. Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation. Leuk Lymphoma. 2002 Mar; 43(3):503-10.
-
Anderson LD, Mori S, Mann S, Savary CA, Mullen CA. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease. Cancer Res. 2000 Oct 15; 60(20):5797-802.
-
Anderson LD, Savary CA, Mullen CA. Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease. Blood. 2000 Apr 1; 95(7):2426-33.
-
Anderson LD, Petropoulos D, Everse LA, Mullen CA. Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine. Cancer Res. 1999 Apr 1; 59(7):1525-30.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
